New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors | ALK

New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors

Link

https://www.globenewswire.com/news-release/2026/03/04/3249131/0/en/New-data-rev…

Created date

Wed, 03/04/2026 - 12:00

Nasdaq ID

3249131

Last updated: 04.03.2026